NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)
CUSIP: 64125C109
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 99,963,154
- Total 13F shares
- 95,485,987
- Share change
- +651,709
- Total reported value
- $10,559,467,994
- Put/Call ratio
- 68%
- Price per share
- $110.60
- Number of holders
- 579
- Value change
- +$7,244,935
- Number of buys
- 252
- Number of sells
- 331
Quarterly Holders Quick Answers
What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 64125C109:
Top shareholders of NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
12%
from 13D/G
|
14,782,722
|
$2,017,841,559 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
10,119,641
|
$1,381,330,998 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
4.8%
from 13D/G
|
4,891,137
|
$667,654,967 | — | 31 Dec 2024 | |
| DODGE & COX |
13D/G
13F
|
Company |
5.6%
|
5,534,624
|
$585,341,834 | $0 | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.5%
|
2,538,109
|
$346,451,879 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.5%
|
2,489,397
|
$339,802,691 | — | 31 Dec 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.9%
|
1,896,891
|
$258,925,561 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,875,062
|
$255,522,640 | — | 31 Dec 2024 | |
| Bellevue Group AG |
13F
|
Company |
1.8%
|
1,820,000
|
$248,430,000 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
1,573,297
|
$214,755,512 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
1,490,513
|
$203,456,000 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.5%
|
1,457,425
|
$198,938,515 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.4%
|
1,371,186
|
$187,166,892 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.1%
|
1,070,096
|
$146,068,108 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.98%
|
983,799
|
$134,288,542 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.98%
|
981,939
|
$134,034,676 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.95%
|
949,512
|
$129,608,391 | — | 31 Dec 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.95%
|
944,738
|
$128,956,000 | — | 31 Dec 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.94%
|
938,120
|
$128,053,380 | — | 31 Dec 2024 | |
| DSM CAPITAL PARTNERS LLC |
13F
|
Company |
0.93%
|
932,595
|
$127,299,219 | — | 31 Dec 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.9%
|
901,790
|
$123,094,335 | — | 31 Dec 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.9%
|
898,293
|
$122,616,993 | — | 31 Dec 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.89%
|
892,000
|
$121,758,000 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.87%
|
870,290
|
$118,794,538 | — | 31 Dec 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.86%
|
862,000
|
$117,663,000 | — | 31 Dec 2024 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.84%
|
843,902
|
$115,192,620 | — | 31 Dec 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.82%
|
820,694
|
$112,024,734 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.79%
|
794,118
|
$108,399,391 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
762,557
|
$104,089,031 | — | 31 Dec 2024 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.75%
|
748,359
|
$102,151,000 | — | 31 Dec 2024 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.74%
|
737,772
|
$100,705,000 | — | 31 Dec 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.72%
|
720,500
|
$98,348,250 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.61%
|
611,119
|
$83,417,744 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.61%
|
608,935
|
$83,119,630 | — | 31 Dec 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.58%
|
577,616
|
$78,844,584 | — | 31 Dec 2024 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.56%
|
557,904
|
$76,153,896 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.55%
|
550,157
|
$75,101,022 | — | 31 Dec 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.51%
|
514,082
|
$70,172,000 | — | 31 Dec 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.51%
|
512,820
|
$69,999,930 | — | 31 Dec 2024 | |
| Fiera Capital Corp |
13F
|
Company |
0.5%
|
499,109
|
$68,128,379 | — | 31 Dec 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.48%
|
480,565
|
$66,245,719 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.48%
|
484,034
|
$66,070,628 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.46%
|
461,782
|
$63,033,245 | — | 31 Dec 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.45%
|
453,091
|
$61,846,922 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.42%
|
419,428
|
$57,251,924 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.42%
|
418,712
|
$57,154,188 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.41%
|
413,479
|
$56,441,001 | — | 31 Dec 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.39%
|
394,652
|
$53,869,998 | — | 31 Dec 2024 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.39%
|
393,710
|
$53,741,415 | — | 31 Dec 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.36%
|
355,058
|
$48,465,417 | — | 31 Dec 2024 |
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.